Dr Reddy's Laboratories (Dr Reddy's Laboratories) Gross-Profit-to-Asset % : 46.85% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Dr Reddy's Laboratories's annualized Gross Profit for the quarter that ended in Dec. 2023 was $2,028 Mil. Dr Reddy's Laboratories's average Total Assets over the quarter that ended in Dec. 2023 was $4,328 Mil. Therefore, Dr Reddy's Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 46.85%.

Dr Reddy's Laboratories Gross-Profit-to-Asset % Historical Data

The historical data trend for Dr Reddy's Laboratories's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Gross-Profit-to-Asset % Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

35.77

39.66

41.87

39.90

43.68

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															52.73	45.68	48.18	47.11	46.85

Competitive Comparison of Dr Reddy's Laboratories's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Gross-Profit-to-Asset % falls into.

Dr Reddy's Laboratories Gross-Profit-to-Asset % Calculation

Dr Reddy's Laboratories's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2023 )	/	( (Total Assets (A: Mar. 2022 )	+	Total Assets (A: Mar. 2023 ))	/ count )
	=	1693.8	/	( (3843.399	+	3912.334)	/ 2 )
	=	1693.8	/	3877.8665
	=	43.68 %

Dr Reddy's Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	2027.676	/	( (4177.465	+	4478.367)	/ 2 )
	=	2027.676	/	4327.916
	=	46.85 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Dr Reddy's Laboratories Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.